Terbinafine hydrochloride

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

EffectivenessOtomycosis

73 competitors in Effectiveness

#DrugCompanyPhaseTrials

1

Kesimpta

Novartis

Phase 3

22

Actos

Takeda

Phase 3

13

Mounjaro

Eli Lilly

Phase 3

14

Nicotine Free Cigarettes

Pfizer

Phase 3

35

Botulinum Toxin a

GSK

Phase 3

16

Droxia

TTheravia

Phase 2

97

Gemzar

Johnson & Johnson

Phase 2

18

Haldol

DDePuy Orthopaedics

Phase 2

19

Welireg

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2

110

Temodar

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2

1Show 28 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Onychomycosis2 trials

Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis

Completed·Novartis·Phase 3·NCT00459537·1,029 enrolled

Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis

Completed·NNexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)·Phase 1·NCT00691184·56 enrolled

Tinea Pedis2 trials

Three-Arm Trial of Novel Treatment for Tinea Pedis

Completed·SSouth End Skin Care·Phase 2·NCT03135912·90 enrolled

SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS

Unknown status·UUnited Laboratories·Phase 2·NCT03999437·42 enrolled

LAM2 trials

Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg

Completed·Mylan Pharmaceuticals Inc·Phase 1·NCT00647647·36 enrolled

Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg

Completed·Mylan Pharmaceuticals Inc·Phase 1·NCT00648713·36 enrolled

Tinea Capitis2 trials

Terbinafine Compared to Griseofulvin in Children With Tinea Capitis

Completed·Novartis·Phase 3·NCT00117767·720 enrolled

Terbinafine Compared to Griseofulvin in Children With Tinea Capitis

Completed·Novartis·Phase 3·NCT00117754·720 enrolled

Efficacy and Safety1 trial

Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis

Completed·NNitric BioTherapeutics, Inc·Phase 2·NCT01080079·168 enrolled

4 more indications

Effectiveness1 trial

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

Completed·Novartis·N/A·NCT00002394·30 enrolled

Fasting Conditions1 trial

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions

Completed·—·Phase 1·NCT01286688·36 enrolled

Otomycosis1 trial

Terbinafine Hydrochloride for the Treatment of Otomycosis

Not yet recruiting·—·N/A·NCT07152327·50 enrolled

Fed1 trial

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions

Completed·—·Phase 1·NCT01286701·18 enrolled

Details

Drug Info

Related News